Back to all papers

Multimodality Imaging in Contemporary Cardio-Oncology: Beyond Ejection Fraction.

November 8, 2026pubmed logopapers

Authors

Veglia MG,Guasti S,Romano G,Oliva S,Tedeschi A,Canale ML,Frangione A,Santagata J,Fabiani I,Piroli F,Musella F,Oliva F,Nardi F,Grimaldi M

Affiliations (17)

  • U.O.C. Cardiologia "Unità Coronarica e Emodinamica", Ospedale Madonna delle Grazie, 81740 Matera, Italy.
  • S.C. Cardiologia 4-Diagnostica e Riabilitativa, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milano, Italy.
  • Azienda Ospedaliera Villa Sofia Cervello, UOC Cardiologia Presidio Cervello, 90146 Palermo, Italy.
  • UOSD Cardiologia di Interesse Oncologico, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy.
  • UOC Cardiologia e UTIC, Ospedale Guglielmo da Saliceto di Piacenza, 29121 Piacenza, Italy.
  • UOC Cardiologia, Ospedale Versilia, Azienda USL Toscana Nord Ovest, 55041 Toscana, Italy.
  • Cardiology and Arrhythmology Clinic, Polytechnic University of Ancona, 60126 Ancona, Italy.
  • Division of Cardiology, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.
  • Dipartimento Cardiotoracico, Fondazione Toscana Gabriele Monasterio, 56124 Pisa, Italy.
  • Dipartimento di Cardiologia, Arcispedale Santa Maria Nuova, AUSL Reggio Emilia-IRCCS, 42123 Reggio Emilia, Italy.
  • Department of Clinical Science and Education, Karolinska Institutet, SE-118 83 Stockholm, Sweden.
  • Cardiology Department, Santa Maria delle Grazie Hospital, 80078 Naples, Italy.
  • Unità di Cure Intensive Cardiologiche, Cardiologia 1-Emodinamica, Dipartimento Cardiotoracovascolare "A. De Gasperis", ASST Grande Ospedale Metropolitano Niguarda, 20162 Milano, Italy.
  • Dipartimento di Cardiologia, Ospedale Santo Spirito, Casale Monferrato, 15033 Alessandria, Italy.
  • U.O.C. Cardiologia-UTIC, Ospedale Miulli, Acquaviva delle Fonti, 70021 Bari, Italy.
  • ANMCO-Associazione Nazionale Medici Cardiologi Ospedalieri, 50121 Firenze, Italy.
  • HCF Fondazione ANMCO per il tuo Cuore ETS, 50121 Firenze, Italy.

Abstract

<b>Background</b>: Cancer therapy-related cardiac dysfunction (CTRCD) may develop before symptoms or a measurable decline in left ventricular ejection fraction (LVEF). Surveillance therefore requires assessment beyond LVEF alone. <b>Content</b>: This narrative review examines cardiotoxic mechanisms, imaging findings, and treatment-specific surveillance. Transthoracic echocardiography with LVEF and global longitudinal strain remains the first-line approach. Myocardial work may provide additional information, but oncology-specific action thresholds remain unvalidated. Cardiac magnetic resonance complements echocardiography when measurements are inconclusive or tissue characterization is required. Mapping abnormalities are nonspecific and do not independently establish treatment-related injury. Nuclear imaging addresses selected diagnostic questions; fibroblast activation protein inhibitor PET remains investigational. Artificial intelligence may support image analysis and data integration, although evidence from general cardiovascular populations requires oncology-specific validation. An algorithm and surveillance matrix link clinical findings, treatment, baseline risk, imaging, and biomarkers. <b>Conclusions</b>: A tiered approach organizes surveillance around specific clinical questions. Earlier detection should be distinguished from demonstrated clinical benefit: evidence that imaging-guided strategies improve long-term cardiovascular outcomes remains limited. Prospective studies are needed to validate emerging markers, AI applications, and the clinical and economic effects of integrated surveillance pathways.

Topics

Journal ArticleReview

Ready to Sharpen Your Edge?

Subscribe to join 11k+ peers who rely on RadAISlice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.